Strativa Pharmaceuticals today announced that the U.S. Food and Drug Administration (FDA) has approved Zuplenz® (ondansetron) oral soluble film for the prevention of postoperative, highly and moderately emetogenic cancer chemotherapy-induced, and radiotherapy-induced nausea and vomiting. Zuplenz, a unique formulation of ondansetron, is the first oral soluble film approved by the FDA as a ...
Posted by Vyvanse In the News on at
Filed under Vyvanse News · Tagged with Cancer, Chemotherapy, Fda, Fda Approval, Fda Approved, Food And Drug, Food And Drug Administration, Food And Drug Administration Fda, Nausea And Vomiting, Ondansetron, Oral, Pharmaceuticals, Prevention
A local company is working to improve pharmaceuticals by making existing drugs better and safer for the patients who need them.
67 WALL STREET, New York - November 2, 2009 - The Wall Street Transcript has just published its Pharmaceuticals Report offering a timely review of the sector to serious investors and industry executives. This 76 page feature contains expert industry commentary through in-depth interviews with public company CEOs, Equity Analysts and Money Managers. The full issue is available by calling (212 ...
Posted by Vyvanse In the News on at
Filed under Vyvanse News · Tagged with Company Ceos, Data Transformation, Depth Interviews, Equity Analysts, Industry Commentary, Industry Executives, Investors, Money Managers, November 2, Page Feature, Pharmaceuticals, Phase Iii, Piper, Wall Street, Wall Street Transcript, Xifaxan, Yahoo, Yahoo Finance
